AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$7.49
-$0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM ET
$7.49
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 86.42M |
Short-Term Investments | 30.1M |
Long-Term Investments | 11K |
Other Long-Term Assets | -2.86M |
Receivables | 4.78M |
Inventory | n/a |
Other Current Assets | -57.01K |
Total Current Assets | 121.24M |
Property-Plant & Equipment | 1.59M |
Goodwill & Intangibles | 33.73M |
Total Long-Term Assets | 32.47M |
Total Assets | 153.71M |
Account Payables | 7.63M |
Deferred Revenue | 1.46M |
Short-Term Debt | n/a |
Other Current Liabilities | 6.53M |
Total Current Liabilities | 18.59M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 3.21M |
Total Long-Term Liabilities | 4.22M |
Total Liabilities | 22.8M |
Total Debt | 1.25M |
Book Value | 130.9M |
Book Value Per Share | 2.69 |
Common Stock | 223.07M |
Retained Earnings | -181.71M |
Comprehensive Income | -967K |
Shareholders Equity | 130.9M |
Total Investments | 30.11M |
Add to Watchlist
Select watchlists to add or remove AGMB